Federico Ricardo Laham MD

Infectious Diseases, Arnold Palmer Hospital for Children

Education & Training

Baylor College of MedicineMasters in Science (MS), Clinical Scientist Training Program, 2008 - 2010
Baylor College of MedicineFellowship, Pediatric Infectious Diseases, 2006 - 2009
University of Miami/Jackson Health SystemResidency, Pediatrics, 2004 - 2006
University of Miami/Jackson Health SystemInternship, Pediatrics, 2003 - 2004
University of Buenos AiresClass of 2001

Central Florida HIV Trailblazer Award Orlando Chapter of the Sistas Organizing to Survive and Clear Health Alliance, 2019
Exemplary Physician Colleague Award Orlando Health, 2014
Pediatric Subspecialty Faculty Award Arnold Palmer Hospital for Children, 2011
Early Career Award Thrasher Research Fund Grant, 2009
T32 Ruth L. Kirschstein National Research Service Award Department of Health and Human Services, Public Health Service, 2008
Diploma of Honor University of Buenos Aires, 2001
Fellow (FAAP) American Academy of Pediatrics
Join now to see all

PubMed

1 citations
Long-term Health Outcomes After Hospital Discharge Among Children Hospitalized for MIS-C or COVID-19, September 29, 2021, to June 21, 2022.
Shana Godfred-Cato, Amber Kunkel, Joseph Y Abrams, Ami B Shah, Anna Yousaf
The Pediatric Infectious Disease Journal. 2024-11-01
1 citations
Beta-Lactam Allergy De-labeling in a Pediatric Hospital.
Shawn Meehl, Christina Salathe, Chelsea Cooley, Alejandro Jordan-Villegas, Federico R Laham
The Journal of Pediatric Pharmacology and Therapeutics. 2024-04-01
1 citations
Treatments and Severe Outcomes for Patients Diagnosed With MIS-C at Four Children's Hospitals in the United States, March 16, 2020-March 10, 2021.
Ami B Shah, Joseph Y Abrams, Shana Godfred-Cato, Amber Kunkel, Teresa A Hammett
The Pediatric Infectious Disease Journal. 2023-11-01

Is the US Facing a Potential 'Tripledemic' of Flu, RSV and COVID-19?October 26th, 2022
Doctors Expected MIS-C Cases to Surge After the Delta Wave. They Didn'tDecember 14th, 2021
Should Parents with Young Kids 'Bubble Up' This Fall? How to Stay Safe from COVID-19October 14th, 2021
Join now to see all

Member, COVID-19 Medical Management Task Force 2020 - Present
Chairman, Infection Control and Prevention, Orlando Health 2012 - Present
Member, Antibiotic Stewardship Program, Orlando Health 2010 - Present
Member, Antibiotic Stewardship Program, Florida Hospital for Children 2013 - 2019
Vice-Chair, Department of Pediatrics, Arnold Palmer Hospital for Children 2013 - 2015

Site PI“The Association of Kawasaki Disease and COVID-19 with Cardiac Complications: A Focused Sub-study of the International Kawasaki Disease Registry (IKDR)” Sponsor: The Hospital for Sick Children2020 - Present
Site PI“Airway microbiome and age 6y asthma phenotypes in 2 diverse multicenter cohorts” - NIH2016 - Present
Site PI“Cohort Study of Severe Bronchiolitis and Risk of Recurrent Wheezing” - NIH2011 - 2016
Sub-Investigator"A phase II, multicenter, randomized, observer-blind, placebo-controlled study to evaluate the immunogenicity, safety and tolerability of CSL’s 2009 H1N1 influenza vaccine in a healthy pediatric population." - P. Piedra, PI. CSL, Sponsor2009 - 2010
Sub-investigator“Pre-clinical Evaluation of Candidate RSV Vaccines in the Cotton Rat Model” The goal was to evaluate candidate RSV vaccines for efficacy immunogenicity and pathology in the cotton rat model."2008 - 2010
Sub-Investigator“Immunopathogenesis of Bronchiolitis” Clinical and in vitro study to examine the utility of nasal-wash lactate dehydrogenase level as a biomarker of bronchiolitis severity.2008 - 2009